Brief Educational Video plus Telecare to Enhance Recovery for Older Emergency Department Patients with Acute Musculoskeletal Pain: an update to the study protocol for a randomized controlled trial

Trials. 2022 May 12;23(1):400. doi: 10.1186/s13063-022-06310-z.

Abstract

Background: This update describes changes to the Brief Educational Tool to Enhance Recovery (BETTER) trial in response to the COVID-19 pandemic.

Methods/design: The original protocol was published in Trials. Due to the COVID-19 pandemic, the BETTER trial converted to remote recruitment in April 2020. All recruitment, consent, enrollment, and randomization now occur by phone within 24 h of the acute care visit. Other changes to the original protocol include an expansion of inclusion criteria and addition of new recruitment sites. To increase recruitment numbers, eligibility criteria were expanded to include individuals with chronic pain, non-daily opioid use within 2 weeks of enrollment, presenting musculoskeletal pain (MSP) symptoms for more than 1 week, hospitalization in past 30 days, and not the first time seeking medical treatment for presenting MSP pain. In addition, recruitment sites were expanded to other emergency departments and an orthopedic urgent care clinic.

Conclusions: Recruiting from an orthopedic urgent care clinic and transitioning to remote operations not only allowed for continued participant enrollment during the pandemic but also resulted in some favorable outcomes, including operational efficiencies, increased enrollment, and broader generalizability.

Trial registration: ClinicalTrials.gov NCT04118595 . Registered on October 8, 2019.

Keywords: Emergency medicine; Geriatrics; Musculoskeletal pain; Shared decision-making.

Publication types

  • Clinical Trial Protocol
  • Letter

MeSH terms

  • Acute Pain* / diagnosis
  • Acute Pain* / therapy
  • COVID-19*
  • Emergency Service, Hospital
  • Humans
  • Musculoskeletal Pain* / diagnosis
  • Musculoskeletal Pain* / therapy
  • Pandemics
  • Randomized Controlled Trials as Topic
  • SARS-CoV-2
  • Treatment Outcome

Associated data

  • ClinicalTrials.gov/NCT04118595